首页|期刊导航|Neural Regeneration Research|Targeting gangliosides to treat Alzheimer''''s and Parkinson''''s diseases:A disruptive approach with the first-in-class peptide AmyP53

Targeting gangliosides to treat Alzheimer''''s and Parkinson''''s diseases:A disruptive approach with the first-in-class peptide AmyP53

Jacques Fantini Nouara Yahi

Neural Regeneration Research2026，Vol.21Issue(6)：P.2419-2420,2.

Neural Regeneration Research2026，Vol.21Issue(6)：P.2419-2420,2.DOI:10.4103/NRR.NRR-D-25-00076

Targeting gangliosides to treat Alzheimer''''s and Parkinson''''s diseases:A disruptive approach with the first-in-class peptide AmyP53

Jacques Fantini ¹Nouara Yahi¹

作者信息

1. Faculty of Medicine,INSERM UA 16,Aix-Marseille University,Marseille,France
折叠

摘要

关键词

neurodegenerative diseases/parkinsons diseases ad/cognitive functions/Alzheimers/amyloid cascade/monoclonal antibodiesaducanumab/Parkinsons/gangliosides

分类

医药卫生

引用本文复制引用

Jacques Fantini,Nouara Yahi..Targeting gangliosides to treat Alzheimer''''s and Parkinson''''s diseases:A disruptive approach with the first-in-class peptide AmyP53[J].Neural Regeneration Research,2026,21(6):P.2419-2420,2.

Neural Regeneration Research

ISSN：1673-5374

访问量0

下载量0

段落导航